stemsavelogo

Select Country

877-783-6728 (877-StemSave)

StemSave Blog

Stem Cell Wound Treatment Enters Phase II Clinical Trials

Posted by taylor@stemsave.com on Oct 19, 2017 5:00:00 PM

images copy 3.jpg

Sanford Health is heading into the second phase of clinical trials involving autologous (the patient’s own) stem cells to treat non-healing wounds and ulcers on the body. The trial will be recruiting patients 18 and older to continue testing the efficacy of stem cells in treating wounds that would not heal due to a person’s preexisting conditions. People with weakened immune systems could also benefit from this treatment, given that it would prevent the enormous risk of infection that non-healing wounds pose. Additionally, the treatment could even be applied to heal wounds from surgeries, expediting recovery time dramatically.

According to Dr. David Pearce, PhD, and vice president of research at Sanford "This clinical trial can help explore treatments for people with non-healing wounds, including people who have diabetes and others with conditions that affect their quality of life."

Advancements in bioengineering, as demonstrated in this study, should accelerate therapeutic options to treat a wider variety of ailments. By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies soon. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today.

 

The Future of Regenerative Medicine is Now™ 

To view the full article, click here.

 

Topics: autologous stem cells, non-healing wounds, diabetic wounds, leg ulcers, stem cell treatments, regenerative medicine

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

    Recent Posts

    Posts by Topic

    see all